Talk:Syntex

This article is rated Start-class on Wikipedia's content assessment scale.
It is of interest to the following WikiProjects:

Companies

This article is within the scope of WikiProject Companies, a collaborative effort to improve the coverage of companies on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.CompaniesWikipedia:WikiProject CompaniesTemplate:WikiProject Companiescompany articles

??? This article has not yet received a rating on the project's importance scale.

WikiProject Companies To-do:

Here are some tasks awaiting attention:

Article requests : Wikipedia:Requested articles/Business and economics/Companies
Assess : Category:Unassessed company articles
Copyedit : Category:Company articles needing attention
Infobox : Category:Company articles needing infoboxes
Maintain : Portal:Companies
Stubs : Help expand stub articles located at Category:Company stubs
Other :
- Tag company articles with the {{portal|Companies}} template
- Tag company talk pages with the {{WikiProject Companies}} project banner
- Answer requests for comments

Pharmacology

	This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles
???	This article has not yet received a rating on the project's importance scale.

Mexico

	Mexico portal This article is within the scope of WikiProject Mexico, a collaborative effort to improve the coverage of Mexico on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.MexicoWikipedia:WikiProject MexicoTemplate:WikiProject MexicoMexico articles
???	This article has not yet received a rating on the project's importance scale.

It is requested that a photograph be included in this article to improve its quality.
The external tool WordPress Openverse may be able to locate suitable images on Flickr and other web sites.

Upload

Scientific Misconduct - NOT![edit]

This article has a section entitled "Scientific misconduct", stating: "Syntex's submission of a fraudulent toxicology analysis of naproxen largely led to the Food and Drug Administration's uncovering of extensive scientific misconduct by Industrial Bio-Test Laboratories in 1976.[3][4][5][6]" Reading those references, it becomes obvious that Syntex was not involved in the misconduct, but was one among many costumers of the testing company in which misconduct happened. Syntex was not even mentioned by name in references [3] and [4]. Why cite them here? There is already an article about the Bio-Test Laboratories company (http://en.wikipedia.org/wiki/Industrial_Bio-Test_Laboratories) covering the scandal Having a "misconduct" section here is like falsely accusing Syntex of misconduct. Likewise, writing "Syntex's submission of a fraudulent ...." is implying that Syntex might have been aware of the fraudulent nature of the data, which clearly is not the case based on the above references. Finally, reference [6] states that Syntex lost 20 million US$ in sales due to the scandal - by the way: for a product (Naproxene) which is still on the market today and considered safe!92.194.21.100 (talk) 00:33, 5 December 2014 (UTC)[reply]

"Laboratorios Syntex SA" is not "Syntex Corporation"[edit]

There was some confusion on the Infant formula page. The part about Neo-Mull-Soy was linked to the Syntex page which is about "Laboratorios Syntex SA" not "Syntex Corporation" who actually made Neo-Mull-Soy. This page should be renamed "Laboratorios Syntex SA" and a disambiguation page should be provided for "Laboratorios Syntex SA" vs. "Syntex Corporation". Breedentials (talk) 15:59, 21 January 2015 (UTC)[reply]

sera[edit]

sera play baseball 2001:E60:8833:D875:BC01:83BE:7769:8694 (talk) 01:53, 4 February 2023 (UTC)[reply]